An FDA advisory committee narrowly voted in favor of loosening restrictions on peptides over strong objections from agency career scientists. with @berkeleyjr.bsky.social
FDA panel recommends easing restrictions on several peptides, including BPC-157
The panel went against the conclusions of the agency’s career scientists, who said there was not enough evidence to support the move.
nbcnews.com